This month marked the crystal anniversary of the life sciences networking event Knowledge for Growth. The event was a huge success, with 1300+ attendees representing 600+ companies from 20+ countries around the world. The theme for this year was “Precision in Life Sciences”, with the fascinating plenary talks discussing the effect of digitalization on healthcare.
The discovery of antibiotics fundamentally changed healthcare in the 20th century. Deadly infections suddenly became treatable and millions of lives were saved. But excessive antibiotic use in both healthcare and agriculture has allowed some microbes to become resistant. Resistance has even been reported to last resort treatments, like colistin, in the past few years. With classic antibiotics failing, will trivial infections become deadly again or will we manage to find new solutions? In this two-part series, we will look into some of the fundamentally different therapeutics that are being developed as alternatives to traditional antibiotics. In this second installment, we highlight bacteriophages: are they finally ready to take center stage, nearly 100 years after being discovered?
This month marked the crystal anniversary of the life sciences networking event Knowledge for Growth. The event was a huge success, with 1300+ attendees representing 600+ companies from 20+ countries around the world. The theme for this year was “Precision in Life Sciences”, with the fascinating plenary talks discussing the effect of digitalization on healthcare.
The discovery of antibiotics fundamentally changed healthcare in the 20th century. Deadly infections suddenly became treatable and millions of lives were saved. But excessive antibiotic use in both healthcare and agriculture has allowed some microbes to become resistant. Resistance has even been reported to last resort treatments, like colistin, in the past few years. With classic antibiotics failing, will trivial infections become deadly again or will we manage to find new solutions? In this two-part series, we will look into some of the fundamentally different therapeutics that are being developed as alternatives to traditional antibiotics. In this second installment, we highlight bacteriophages: are they finally ready to take center stage, nearly 100 years after being discovered?